The trend now is for pharmaceutical companies to forego the expensive, time consuming and risky transfer process

Chimica Oggi-Chemistry Today presents a Panel Discussion on Custom Synthesis and Contract Manufacturing. This topic is of particular interest to our readers and we have testimony of this because of the high number of companies that showed the willingness to participate to this discussion around a virtual table.

Among others, panelists treated important topics like the partner selection process in the API manufacturing sector and the “must to have” for a CRO/CDMO to be the right partner for a pharmaceutical company; furthermore the CDMOS evolution process that are transforming them in product partners and the main trends in late stage clinical and commercial scale API manufacturing.